Search

Few direct matches — filled in with the latest updates.

Tag: #bd-deals2 results

AstraZeneca: Big BD Deals Persist via Complementarity

AstraZeneca: Big BD Deals Persist via Complementarity

AstraZeneca VP Chen Bing forecasts ongoing large BD deals for Chinese innovative drugs, driven by pipeline complementarity beyond crowded oncology to autoimmunity and cardiovascular fields. AI emerges as key enabler, boosting molecule screening, clinical optimization, and new indications. AstraZeneca highlights partnerships like CSPC for long-acting weight loss drugs.

Anduril Raises $5B on AI Defense Infrastructure

Anduril Raises $5B on AI Defense Infrastructure

Anduril Industries reportedly completed a $5 billion Series H financing at a $61 billion valuation, reinforcing its position as a major defense-technology company. The article highlights its Lattice AI platform, flexible Arsenal-1 manufacturing system, and Palmer Luckey’s view that China’s engineering and manufacturing efficiency could reshape future military competition.